CNC
DGX icon

Citizens & Northern Corp’s Quest Diagnostics DGX Stock Holding History

Citizens & Northern Corp’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Sell
1,540
-10
-0.6% -$1.96K 0.07% 99
2026
Q1 		$304K Hold
1,550
– – 0.08% 106
2025
Q4 		$269K Sell
1,550
-24
-2% -$4.37K 0.07% 114
2025
Q3 		$300K Sell
1,574
-146
-8% -$25.9K 0.07% 106
2025
Q2 		$309K Buy
1,720
+31
+2% +$5.38K 0.08% 106
2025
Q1 		$286K Buy
1,689
+83
+5% +$13.6K 0.08% 105
2024
Q4 		$242K Buy
1,606
+270
+20% +$42K 0.07% 118
2024
Q3 		$207K Buy
+1,336
New +$200K 0.06% 125
2017
Q2 		– Sell
-2,124
Closed -$209K – 96
2017
Q1 		$209K Buy
+2,124
New +$202K 0.17% 90

Other funds holding DGX

EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

Citizens & Northern Corp's DGX Position: Q2 2026 in Review

Citizens & Northern Corp reduced its Quest Diagnostics (DGX) stake by 0.65% in Q2 2026, selling an estimated $1.96K and leaving 1,540 shares worth $326K. The position accounts for 0.07% of the portfolio, ranked #99.

Citizens & Northern Corp first reported a position in DGX in Q1 2017 and has held it in 9 quarters since. 210 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Citizens & Northern Corp held 1,540 shares of Quest Diagnostics worth $326K as of Q2 2026.
  • Citizens & Northern Corp sold 10 Quest Diagnostics shares in Q2 2026, an estimated $1.96K.
  • Quest Diagnostics made up 0.07% of Citizens & Northern Corp's portfolio in Q2 2026, its #99 holding.
  • Citizens & Northern Corp first reported a position in Quest Diagnostics in Q1 2017 and has held it in 9 quarters since.
  • 210 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Citizens & Northern Corp's 13F filing for Q2 2026, filed 17 Jul 2026.